Navigation Links
Warfarin’s Anti-clotting Property May Cause Hemorrhagic Stroke

Warfarin, an anti-clotting drug given to patients suffering from atrial fibrillation has proved effective //by reducing the number of strokes due to clotting.

However, its anti-clotting property has led to an increase in the number of strokes caused by bleeding to the brain particularly in patients over the age of 80, according to a new study.

Warfarin was earlier used as rat poison, after research in the nineties suggested Warfarin reduced the risk of ischemic stroke it became a standard treatment for people suffering from atrial fibrillation.

Matthew Flaherty, the lead researcher and a neurologist at the University of Cincinnati in Ohio, said the study results don’t necessarily mean that use of warfarin should be given up, but motivate physicians to make sure that the drug is being used appropriately.

"Doctors can use these findings to make sure they are weighing the risks and benefits of warfarin use for their patients," he said.

“The benefits of anti-clotting drugs are "undeniable" for some patients, such as those who have had blood clots,” Dr. Flaherty said.

The researcher said more research was needed to find anti-coagulants safer than warfarin to help patients who suffer from hemorrhagic strokes.

All cases of intracerebral hemorrhage (bleeding inside the brain) in the Cincinnati area between 1988 and 1999 were examined by the study. The cases connected with the use of blood-thinning drugs soared to 4.4 cases per 100,000 people by 1999 from 0.8 cases per 100,000 in 1988. In comparison, the rate of hemorrhagic strokes associated to warfarin use, rose to 45.9 per 100,000 in 1999 from 2.5 per 100,000 in 1988.

The study notes that, between 1993 and 1999, the rate of ischemic stroke in patients suffering from atrial fibrillation remained fixed at about 22 per 100,000. But previous research has shown that warfarin use has halved the rate of ischemic stroke in pat
'"/>




Page: 1 2

Related medicine news :

1. Aspirin surpasses Modern Anti-clotting Drugs
2. Fruits And Vegetables Have Arthritis Risk Reducing Property
3. Cancer-causing Property Of Teflon Leaves US Regulators Concerned
4. Opposition against Amendments in the Intellectual Property Law
5. Is Diabetes the Leading Cause of Kidney Failure in India
6. Antibiotics Dangerous for Diarrhoea in Children Caused by E.Coli
7. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
8. Breast Cancer Surgery Causes Psychological problems
9. Arthritis Drug May Cause Liver Damage
10. Causes of weakness in the aged
11. Gene Mutation Causes Ovarian Failure
Post Your Comments:
(Date:12/5/2009)... significant scientific advances in the field of blood cancers, ... of how certain diseases progress in order to discover ... care. Research presented today at the 51st Annual Meeting ... therapies for managing multiple myeloma, the importance of advance ...
(Date:12/5/2009)... Leukemia and myeloproliferative disorders are serious and ... the 51st Annual Meeting of the American Society ... improved diagnostic methods for patients suffering from acute ... leukemia, and myelofibrosis that are based on a ...
(Date:12/5/2009)... AVIVA today announced the launch of International Solutions, an innovative new ... of its UK equivalent. In addition to offering customers the flexibility ... their needs and budgets, International Solutions enables customers to tailor their ... , ...
(Date:12/4/2009)... Care Investment Trust Inc. (NYSE: CRE ) ("Care" ... declared a dividend of $0.17 per share of common stock. ... of record on December 14, 2009. ,, ... a real estate investment and finance company investing in healthcare-related real ...
(Date:12/4/2009)... American Association of Homes and Services for the Aging (AAHSA) ... and Supportive Services (CLASS) provisions remain in the final health ... support to elders, people with disabilities and their caregivers. ... reform bill that will make it affordable to care for ...
Breaking Medicine News(10 mins):Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2
... link to heart disease to rest , , MONDAY, Jan. 26 ... acids found in vegetable oils, nuts and seeds possibly being ... from the American Heart Association claims. , "There has been ... fatty acids might be bad," said William S. Harris, the ...
... AFL ) announced today that it will release ... 2, 2009. , In conjunction ... meeting on Tuesday, February 3, 2009. During the ... discuss Aflac,s fourth,quarter and year-end results. Following Mr. Amos, ...
... Inc. (Pink Sheets: NEPH), a medical device company developing ... and water purification, today announced that its common stock ... symbol "NEPH." The Company also announced that its ... NYSE Alternext US LLC (formerly, the American Stock Exchange ...
... Nonin Medical, Inc., a leading,innovator of physiological ... Continua(TM) Certified product. The Nonin 2500 PalmSAT(R),handheld pulse ... be certified to meet,the Continua design guidelines. With ... the process of certification, Nonin Medical plans,to offer ...
... - January 26, 2009 - A study published in ... use of certain medications in elderly populations may be associated ... to anticholinergic medications, a type of drug used to treat ... on over 500 relatively healthy men aged 65 years or ...
... SAN JOSE, Calif., Jan. 26 VNUS(R) Medical,Technologies, Inc. (Nasdaq: ... for,the minimally invasive treatment of venous reflux disease, announced today,that ... quarter ended,December 31, 2008, after the close of market on ... host its regular quarterly teleconference at 2:00 p.m. PT /,5:00 ...
Other Medicine News:Health News:Omega-6 Fatty Acids Can Be Good for You 2Health News:Omega-6 Fatty Acids Can Be Good for You 3Health News:Aflac Incorporated To Release Fourth Quarter Results on February 2, 2009 2Health News:Nephros Common Stock Now Quoted in Pink Sheets 2Health News:Nephros Common Stock Now Quoted in Pink Sheets 3Health News:Nonin Medical, Inc. Makes History With the First Continua(TM) Certified Product 2Health News:Nonin Medical, Inc. Makes History With the First Continua(TM) Certified Product 3Health News:Common medication associated with cognitive decline in elderly 2Health News:VNUS Medical Technologies to Report Fourth-Quarter 2008 Results and Webcast Teleconference on February 10 2
(Date:12/4/2009)... OMAHA, Neb., Dec. 4 Amber Pharmacy announced today ... Health Care, Inc. (ACHC) for specialized pharmacy services. For ... care programs and services to meet the unique needs ... leading providers of services to transplant programs. They work ...
(Date:12/4/2009)... Shared Imaging, LLC, an independent provider of ... for hospitals and healthcare providers, is excited to ... for Ambulatory Health Care, a nationally-recognized, prestigious gold ... patient care. Shared Imaging accreditation is system-wide for ...
(Date:12/4/2009)... imported drugs often stored in tin cans and car trunks ... advocacy group RetireSafe urged the Senate to defeat the Dorgan ... said, "Senator Dorgan,s importation amendment is poised to open our ... and our health to be endangered. We could soon ...
Breaking Medicine Technology:Amber Pharmacy Earns Accreditation From ACHC 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2Particles Detected in Vials from Genzymes Plant Not Expected to Impact Aldurazyme or Naglazyme 61330 1Particles Detected in Vials from Genzymes Plant Not Expected to Impact Aldurazyme or Naglazyme 61330 2Particles Detected in Vials from Genzymes Plant Not Expected to Impact Aldurazyme or Naglazyme 61330 3Michael S Burg Appointed as Co Lead Counsel in the Yasmin Yaz Multidistrict Litigation 61325 1Michael S Burg Appointed as Co Lead Counsel in the Yasmin Yaz Multidistrict Litigation 61325 2New Database from ANSI AAMI ASTM International and DIN Provides Centralized Source of Information for Medical Device Professionals 6259 1New Database from ANSI AAMI ASTM International and DIN Provides Centralized Source of Information for Medical Device Professionals 6259 2New Database from ANSI AAMI ASTM International and DIN Provides Centralized Source of Information for Medical Device Professionals 6259 3
The full body blanket provides coverage to the entire patient....
The upper body blanket is typically used for abdominal or lower body procedures. The upper body blankets warms the upper torso and arms. A clear drape is included to cover and warm the intubated pati...
This product is for the lower body and uses a Convective Warming System which is both soft and comfortable. Constructed of 2-ply material consisting of polyethylene film inner layer and non-woven out...
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
Medicine Products: